3 in 4 Patients Quit GLP-1 Drugs Within 2 Years as Hunger and Weight Rebound

3 articles · Updated · health.yahoo.com · Jul 2

Nearly three in four people taking GLP-1 drugs for weight loss stop within two years, and doctors say discontinuation often brings stronger hunger, the return of “food noise,” weight regain and weaker blood-sugar control.
Within weeks, appetite-suppressing effects begin to fade as stomach emptying and brain reward signals return toward baseline; semaglutide can remain in the body about five weeks, tirzepatide roughly four to five weeks.
About two-thirds of lost weight came back within a year for semaglutide users who stopped without restarting treatment in the STEP 1 extension trial, along with some lost gains in blood pressure, cholesterol and glucose control.
Just 14% of people who discontinued in a 2026 study adopted structured lifestyle changes, while more than one-quarter switched drugs and nearly one in five restarted their original GLP-1 within about six months.
Doctors say stopping is safest as a planned transition—often with tapering, protein intake of 0.5 to 0.7 grams per pound, and two to three weekly strength sessions—because obesity usually requires long-term management.